The investigation concluded that multiple lower than expected myog quality control results were obtained using a single non-vitros quality control level in combination with a vitros 5600 integrated system.The investigation could not determine a definitive assignable cause.A within run vitros tt4 marker precision test, used to assess instrument function, was not performed, therefore the vitros 5600 system could not be entirely ruled out as a contributing factor.Based on historical quality control results, a vitros myog reagent performance issue is not a likely contributor to the event, however the possibility that an unexpected vitros myog reagent performance issue or a pre-analytical sample handling issue contributing to the results could not be entirely ruled out.A definitive assignable cause for the event could not be determined.
|
The customer observed multiple lower than expected vitros myog results obtained from a single non-vitros biorad quality control fluid processed on a vitros 5600 integrated system.Biorad l5 control results of 110.773, 107.156, 116.864, 114.667, 113.300, 115.402, 115.048, 109.252, 111.79, and 115.014 ng/ml versus customer established baseline mean 127.95 ng/ml.A biased result of the direction and magnitude observed may lead to inappropriate physician action if it were to occur undetected with patient samples.Ortho has not been made aware of any erroneous vitros myog patient results obtained or reported from the laboratory over the time frame of the event, however, the investigation cannot conclude that patient sample results were not affected or would not be affected if the event were to recur undetected.There was no reported allegation of patient harm as a result of this event.This report is number two of two 3500a forms filed for this event, as two devices were affected.(b)(4).
|